ABSTRACT
Introduction
Gastroschisis (GTS) is a congenital malformation of the abdomen characterized by a ventral defect on the right of the intact umbilical cord, with protrusion of the abdomen organs, generally the intestine 1, 2, 3, 12 .
The intestine, outside the abdominal cavity is unprotected, having as consequences edema, thickening and a fibrin layer over the intestinal serosa taking it to a temporary dysfunction of its physiology 4 . Morbidity and mortality of the delay in the beginning of the intestine functioning associated to a rare prevalence of this disease, has motivated a variety of research centers into looking for solutions in studies using experimental animal models (sheep, rabbits, rats and chicken embryos) 5, 6, 14, 15 . One of the main objectives in the gastroschisis treatment is to prevent the harm to the fetus's intestine in small animals such as the rats because it is possible and has additional advantages like low costs, increased number of fetus per brood and for properly imitate the physiopathology of the human gastroschisis 6 .
The glutamine is an amino acid with an increased concentration of blood being especially used by the cells that show high numbers of renovation, like the enterocytes and leucocytes 7, 8, 19 . In addition, it is released in fetal circulation by placental synthesis and by maternal blood 8, 16 . However, the objective of this study is to validate the gastroschisis experimental model in rats and evaluate the action of glutamine used during pregnancy over the body weight and the morphometrical changes of the fetuses' intestine.
Methods
The Twelve female rats Wistar, 90 days weighing from 230 to 250g, coming from the central animal house of UFMT, were used in this study. The animals were separated into individual cages, a female and a male for mating. The couple was kept together for two nights. When checking the female vagina, the vaginal stain of sperm, the pregnancy is confirmed, classifying this as day zero of pregnancy and established as the probable brood day having the twenty second day subsequently. After mating, females are put in a quantity of two, per acrylic cage, having ration and water being offered to them ad libitum, and kept in an atmosphere of 24 ± 1ºC, relative humidity of 55% and light cycle from 07 to 19 hours.
Animals were divided in two groups: a) Group I (n=6 female rats, 71 fetuses), no glutamine supplementation; b) Group II (n=6 female rats, 75 fetuses) in which glutamine was supplemented during all pregnancy (Figure 1) .
The product used for glutamine supplementation was Glutamax ® (Vitafor, Brazil). To every five grams this product supplies an energetic value of twenty kilo-calories. The offered dosage in this study was of 2gr/kg of weight/day. As the animals' average weigh before mating was of 250gr, we offered a standard measure of enteral glutamine equivalent to 500mg per day.
Therefore, each powder formulation equivalent to 500mg was diluted in 1 ml of water and given as gavage once a day in the afternoon, in the supplementation constituent group during all pregnancy. Animals that did not make use of glutamine only received a standard isocaloric diet from the UFMT laboratory (Labina ® , Ralston Purina, Brazil).
All animals went through surgery by the same researcher.
At the 18 th day 6 of pregnancy the animal was taken to the procedure room and anesthetized with an intramuscular injection of ketamina-S ® 50mg/ml in the dosage of 1,26 ml/kg (ketamine hydrochloride, chemical products Cristalia) associated to Xylazine 2%, 10 mg/ml in a dosage of 0,42ml/kg (Ronpun ® , Bayer).
A medium cut of 3 cm was done, exposing extra abdomen an uterine malformation. In the first moment a counting on the number of fetuses in the uterine malformation is done and it is also established which fetus will be used in the gastroschisis model. The fetus abdomen is carefully dissected with a medium cut and the intestine removed in parts, from the pyloric area to the superior rectum. The intestine part is weighed and by using
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Statistical data was organized in the Microsoft Office Excel 2010 program. All the variability measurements described were graphically represented in boxplot having defined the superior, inferior, medium limits, percentiles and quartiles.
Such analyses described were done in Microsoft Office Excel 2010 and the statistical analysis in the Minitab 14 program. To compare both groups Analysis of variance (ANOVA) was used for the repeated measurements. The "t" test was used in the study referring to the mean in the groups. In all tests the trustness level chosen was fixed in 0.05 or 5% (alpha=5%) used for a rejection index of nullity hypothesis.
Results

Body weight
The mean of the body weight for the fetus in Group I (no glutamine) were: control (CI) 3.61 gr (±0.91) and gastroschisis (GTSI) 3.5gr (±0.93). The mean of the body weight for the fetuses in Group II (with glutamine) were: control (CII) 3.53gr (±0.86) and gastroschisis (GTSII) de 3.59gr (±0.85).
The comparative analysis of the body weight mean either in the group analysis that took glutamine (inter group) or the ones which went through intervention for the gastroschisis model (intra group) was similar (p>0.05) ( Figure 5 ).
Intestine weight
The intestine weight mean (PI) for the fetus in Group 
Intestine length
The intestine length mean (CI) for the fetuses in Group I were: CI 125.41mm (±18.92) and in GTSI 72.63mm (±18.36).
The intestine length was bigger in the control subgroup (p<0.05;
CI vs GTSI).
The mean for the fetuses in Group II were: CII 131.86mm (±20.47) e no GTSII 77.66mm (±18.61) with a longer extension for fetuses with gastroschisis (p<0.05; CII vs GTSII). However, when groups are compared one to another, there is no statistical difference. Data is shown right below in Figure 7 .
Intestine and body weight
In the analysis of this variable, in Group I and Group II the mean found in the gastroschisis subgroup were bigger compared to the subgroup control. In the comparison of the relation intestine weight and body weight between the different groups, it was not seen a significant statistical variation. Data is shown in Figure 8 . Figure 9 . 
Intestine body/intestine length
In the relation between intestine weight and intestine length the mean found in Group I were: CI 79.05 (±23.68), and GTSII: 287.10 (±85.50). The relation intestine weight and intestine length PI/CI in the fetuses CI and GTSI showed a statistical difference (p<0.05; CIxGTSI).
The mean found in Group II in relation to PI/CI were 
Body weight -Intestine weight
The mean with the difference of the body weight and the intestine weight (PC-PI) in group I were: CI: 3.51 (±0.88) varying 
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Discussion
Though the gastroschisis survival rate is of 90% in several neonatal intensive therapy centers, its morbidity remains high due to the intestine dysfunction and the difficulty in the fetus's nutrition [9] [10] [11] [12] [13] .
So, periods of nutritional therapy are necessary, usually by parenteral nutritional therapy with oral diet being introduced later on. This attitude increases bad consequences after the closure of gastroschisis as risks of infection, metabolism disorder, growth delay and cholestatic liver disease 9, 12 .
However, all effort has to be done to search for alternatives in the early diagnosis and in all the treatment, especially in nutritional state to improve the morbidity and mortality rate. As it is a rare disease several research centers are motivated to look for experimental models in animals to reproduce this effect 5, 6, 14, 15 .
In 2001, Correia-Pinto 6 proposed a new model, in rats, that is being validated, adapted and developed in other research centers for the gastroschisis production and gradually used as an example in experiments to test medicaments and therapeutical interventions of this rare illness 6 . The models in rats it is possible to obtain a bigger number of fetus per brood, with the possibility of increasing the quantity of therapeutical interventions for each fetus studied.
The importance of this theme concerning our working field and the perspectives of having experimental studies that may contribute for the improvement of knowledge and treatment of gastroschisis motivated the validation of this experimental model in rats. Besides, the present study tried to associate the glutamine supplementation during the pregnancy in rats with fetuses which were taken to the gastroschisis model to study its action in the intestine morphology.
There is no evidence in the literature about the actual influence of glutamine supplementation during pregnancy, but many studies show that the transport and glutamine metabolism during fetal development exhibit unique characteristics, and the amino acid that has higher placental flow to the fetus being released in fetal circulation by placental synthesis and by the very blood circulation maternal 16, 18 . There is a movement of glutamine to the fetus, its contribution over the exposed bowel loops of fetuses with experimental model of gastroschisis was our object of study in this work.
The glutamine supplementation in our research was of 2gr/kg of weight/day, which is equivalent to a standard dosage of 500mg a day. In literature, the used dosages vary, not being possible to find a standard or a consensus about the proper data of glutamine in experimental animals. It is seen in the studies empiric supplementation in newborn, varying from 0.2 to 4gr/kg of weight /day 17, 19 . This way, new researches have to be done to check if the used dosages in this study were not enough and in that way have not changed the macroscopic intestine parameters of the fetuses. The first variable checked was the body weight of the fetus. Studies show that newborn with gastroschisis show less body weight 3, 9, 10, 12 . This observation is also described in the experimental models of gastroschisis in rats. However, in our study, it is described an average weigh of the fetuses which were taken to the gastroschisis model of 3.5gr and in those fetuses that received glutamine was found 3.59gr, not revealing, this way, changes in the body weight between the different groups (p=0.955).
The morphometrical analysis of the intestine weigh shows a statistical difference between the intestine weight of the fetuses control and gastroschisis in the different groups. This data reflects an important change that happens in the gastroschisis in humans referring to the edema and thickness of the intestine 4 , important fact for intestine dysfunction that happens after the birth of the new born ones. Another change seen in gastroschisis is the intestine length which is reduced in the fetuses that went through the experimental model compared to control ones 6 . There is a bigger growth of the intestine in the end of pregnancy mainly due to an increase of the protein synthesis and changes during pregnancy period may shorten the intestine 2, 3 . Consequently, as glutamine is the main item of enterocytes, it was used during all the pregnancy period of time. We had an important statistical difference between the regular individuals (control) the ones that were taken to gastroschisis, with the shortening in the fetus GTS in group I and in group II. But with the supplementation of glutamine, body and intestine length measurements did not show statistical differences between the different groups (p=0.955).
A parameter was introduced in this study the ratio of intestinal to body weight, emphasizes the importance of intestine weight in the fetus's body structure. In the same group, comparing the fetus control and the gastroschisis ones, this relation was 
Conclusions
The gastroschisis experimental model is valid and reproducible. The nutritional therapy with glutamine did not change the morphometrical parameters.
